Treatment with empagliflozin in rats with tacrolimus-induced diabetes reduced hyperglycemia and increased plasma insulin levels and islet size; it also enhanced glucose-induced insulin secretion in isolated pancreatic tissue [154]. This evidence concerns the gene INS and diabetes mellitus.